嘉利國際(01050.HK):訂單表現非常良好 料今年銷售續增
嘉利國際(01050.HK)首席財務官黃浩鈞於傳媒午宴時指,在截至6月底止今財年首季訂單非常良好,承繼去年下半年因中美貿易協定簽訂後的升幅,同時伺服器訂單亦在居家工作後,需求見增長,所以對今年保持審慎樂觀,相信銷售會有增長。
他指,會開拓雲端平台服務商(CSP)客戶市場,同時亦正計劃配合客戶需求,建設海外生產基地,包括泰國和墨西哥,正與合作夥伴商討,冀年底可有消息公布。
今年公司資本開支預期為2億元,用於拓展東莞廠房,相信可以增加80% 產能,最快下月動工,明年上半年完成,將用於伺服器、汽車模組生產。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.